Small molecule inhibitors of Ebola and Lassa fever viruses and methods of use
US11629139B2 · kind B2 · utility
0Cited by
2References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 10, 2018 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Apr 20, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds having a structure of formula (I), compositions and methods useful for the treatment of a disease or infection, such as a viral infection (e.g., Ebola), cancer and obesity: wherein
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.